Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
US7388021B2 · kind B2 · utility
5Cited by
4References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 2005 |
| Grant date | Jun 17, 2008 |
| Priority date | — |
| Expiry date | Jan 22, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/1804
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.